NewAmsterdam Pharma Co N.V.
NAMSW· Nasdaq
Released Feb 28, 2024, before the open
10-K filed Feb 28, 2024, 59 days after period end · 0000950170-24-021668
derived · Computed from the longer spans the company filed.
no prior Q4 2022 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NewAmsterdam Pharma Co N.V. · CIK 1936258 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 28, 2024 · 59 d after period end